Netherlands· NL-6bdac491f0c0
Dusmyla 160 microgram/ml drank
A glycopyrronium bromid product containing glycopyrroniumbromide, registered in Netherlands by Clinigen Healthcare B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium bromid is registered in 12 of 19 countries.
Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Glycopyrronium bromid · ATC A03AB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- GLYCOPYRRONIUMBROMIDE
- Manufacturer
- Clinigen Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- A03AB02
- ATC class
- Glycopyrronium bromid
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id127946
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrronium bromid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAMIDIL AmiHalerZakłady Farmaceutyczne POLPHARMA S.A.
- ItalyGLICOPIRRONIO DOCDOC GENERICI S.R.L.
- SpainAXHIDROX 2,2 MG/PULSACION CREMAIndustrial Farmaceutica Cantabria S.A.
- IcelandEnurev BreezhalerNovartis Europharm Limited*
- SwitzerlandAxhidrox 2,2 mg/Hub, CremeGebro Pharma AG
- United StatesQbrexzaJourney Medical Corporation
- GermanyRybrilaColonis Pharma B.V.
- DenmarkEnurev BreezhalerNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Rybrila
- Germany · Rybrila
- Spain · Axhidrox
- Sweden · Glycopyrronium Cantabria
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95065870-fa7c-4170-a1af-c865ef11e49c GET /v1/drugs/95065870-fa7c-4170-a1af-c865ef11e49c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Drank",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127946_smpc.pdf",
"strength": null,
"atc_label": "Glycopyrronium",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127946",
"excipients": [
"AARDBEIENSMAAKSTOF",
"ARABISCHE GOM (E 414)",
"CITROENZUUR 1-WATER (E 330)",
"GLYCEROL (E 422)",
"GLYCEROLTRIACETAAT (E 1518)",
"MALTODEXTRINE",
"NATRIUMMETHYLPARAHYDROXYBENZOAAT (E 219)",
"NATRIUMPROPYLPARAHYDROXYBENZOAAT",
"SORBITOL, VLOEIBAAR, NIET-KRISTALLISEERBAAR (E 420)",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER, GEZUIVERD"
],
"substances": [
"GLYCOPYRRONIUMBROMIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127946.pdf",
"authorised_at": "2022/09/08",
"procedure_number": "NL/H/5348/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "127946",
"additional_monitoring": "N"
}See everything about glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.